Avaulta Mesh Lawsuit: What you can expect?
If you or a loved one has suffered complications after receiving an Avaulta transvaginal mesh implant, you may be wondering what to expect from the legal process. Here, we’ll provide an overview of the Avaulta mesh lawsuits, including the key legal issues and the compensation that may be available.
What is the Avaulta Mesh?
In addition to treating pelvic organ prolapse (POP), the Avaulta mesh is also used to treat stress urinary incontinence (SUI).The mesh is made of synthetic polypropylene and is implanted through the vagina to support the pelvic organs.
Avaulta is manufactured by Bard Medical, a subsidiary of C.R. Bard, Inc. Bard is one of the leading manufacturers of transvaginal mesh implants, with over two dozen different types of mesh on the market.
Avaulta was first approved by the FDA in 2005 for the treatment of POP. In 2008, the FDA approved the Avaulta Plus system, which included a new type of mesh designed for the treatment of SUI. Since its approval, Bard has sold over 100,000 units of Avaulta mesh.
Avaulta Mesh Lawsuits
Since the FDA approved the Avaulta mesh lawsuit there have been thousands of lawsuits filed against Bard by women who have suffered complications after receiving the implant.
The lawsuits allege that Bard knew or should have known about the risks associated with the Avaulta mesh and failed to warn patients and doctors. The lawsuits also allege that Bard failed to properly test the Avaulta mesh before putting it on the market. To date, Bard has paid out over $1.6 billion to settle Avaulta mesh lawsuits.
Key Legal Issues
The key legal issue in the Avaulta mesh lawsuits is whether Bard failed to warn patients and doctors about the risks associated with the device.
The FDA has received thousands of reports of complications associated with the Avaulta vaginal mesh complications, including pain, infection, and organ perforation. In some cases, the complications are so severe that women have had to have the mesh surgically removed.
In 2012, the FDA issued a warning about the risks associated with transvaginal mesh implants, including the Avaulta mesh. The FDA warned that complications from the mesh are “not rare” and that the benefits of the mesh may not outweigh the risks. Bard stopped selling the Avaulta mesh in 2016 after the FDA issued a “class II” recall of the device.
Compensation Available in Avaulta Mesh Lawsuits
If you or a loved one has been injured by the Avaulta mesh, you may be entitled to compensation for your injuries.
Compensation in Avaulta mesh lawsuits may include:
- Medical expenses
- Lost wages
- Pain and suffering
- Punitive damages
If you have been injured by the Avaulta mesh complications, it’s important to speak with a lawyer to understand your legal rights. People can file a lawsuit alongside Bard and obtain compensation for your injuries. This will help to recover from lost wages, medical bills, pain, and more. The Avaulta lawsuits were consolidated into multidistrict litigation (MDL), which is a type of litigation that consolidates similar lawsuits into one court.